Every major corporation has the same tag line … it’s all about the “experience”.
Their goal’s nothing substantial; just the ephemeral.
Shadow stats reports that real unemployment is at 35%; already way past 1930’s depression-era levels.
We won’t have to go searching for the experience.
It’s coming to us.
Even those still employed are wondering if they’re next or what’s going to happen if/when their pay is cut.
Meanwhile, the market itself has already told us where to go and where to look. The S&P just opened down 2.3% and may be starting the next leg lower.
Is that the place to go … the S&P?
The S&P is probably the most computer controlled, algorithm induced, manipulated market in the world. All eyes focused on it.
Back around 2009 or so, my firm stopped trading the S&P and moved on to a more effective approach.
A strategic view was developed. Trading methods created that were focused on positioning instead of instant (day-trade) gratification.
With that in mind, biotech has been the topic of discussion and analysis. Price action in IBB has been tight and getting tighter. That allows one to take a low-risk short position (not financial advice) if so desired.
At this point, knowing where to go and where to look, may be the only essential experience.